“COVID-19 AND LOW PLATELET COUNT-A RELATIONSHIP”

Abstract 62 | Pdf Downloads 9 | DOI https://doi.org/10.53555/jptcp.v22i3.4433

Page 315-319

TO ASSESS THE EFFICACY OF NAPROXEN AND SULFASALAZINE IN SUBJECTS WITH JUVENILE ONSET ANKYLOSING SPONDYLITIS (10-17 YEARS): A PROSPECTIVE STUDY

Abstract 46 | pdf Downloads 27

Page 303-309

PROGRAMMED DEATH- LIGAND 1 EXPRESSION IN UROTHELIAL CARCINOMA

Abstract 58 | Pdf Downloads 9 | DOI https://doi.org/10.53555/jptcp.v22i3.4417

Page 310-314

Decisions in a Time of Change: New Frontiers in Health Policy, HTAS, and Methods

Abstract 139 | PDF Downloads 157

BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS

Abstract 325 | PDF Downloads 141

COST-SHARING FOR HEALTH CARE SERVICES: AN ALTERNATIVE STRATEGY FOR PHARMACEUTICAL REIMBURSEMENT IN ONTARIO

Abstract 151 | PDF Downloads 118

LA POLYPHARMACIE: ENJEUX METHODOLOGIQUES A CONSIDERER

Abstract 257 | PDF Downloads 312

REGIONAL VARIATIONS IN THE PREVALENCE OF MAJOR CONGENITAL MALFORMATIONS IN QUEBEC: THE IMPORTANCE OF FETAL GROWTH ENVIRONMENT

Abstract 384 | PDF Downloads 159

USING A COMMON FORM FOR CONSISTENT COLLECTION AND REPORTING OF FASD DATA FROM ACROSS CANADA: A FEASIBILITY STUDY

Abstract 374 | PDF Downloads 204

EXPLORING THE DISTRIBUTION OF PRESCRIPTION FOR SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES ACCORDING TO CARDIOVASCULAR RISK FACTORS WITHIN A CANADIAN PRIMARY CARE SETTING

Abstract 237 | PDF Downloads 142